BackInnoCan Pharma Overview

InnoCan Pharma Total Assets

Track InnoCan Pharma's total assets ($10M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Total Assets
$10.35M
↓ 6.20% YoYΔ $-684438.00 vs prior year quarter

Peer trimmed avg / median

Loading

InnoCan Pharma Total Assets History

Loading

InnoCan Pharma vs. peers: Total Assets Comparison

Loading

InnoCan Pharma Total Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

InnoCan Pharma (INNPF) FAQ

InnoCan Pharma posts a total assets of $10M as of June 2026. That compares with $11M in the prior-year period — down 6.2% year over year. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.

In the prior comparable period, InnoCan Pharma's total assets was $11M. The latest reading is $10M — a 6.2% year-over-year decrease (period ending June 2026). Use the history and growth charts on this page for a longer lookback.

Total Assets is one piece of InnoCan Pharma's financial statement story. At $10M, it should be interpreted next to related metrics — for example revenue with costs, assets with liabilities, or income with margins. Stockcircle links those related pages so you can move from this number to the surrounding context quickly.

Context for INNPF's total assets usually means three checks: (1) trend versus prior periods, (2) level versus peers, and (3) consistency with growth and profitability. This page covers the first two; InnoCan Pharma's other metric pages and overview cover the third.

Questions & Answers